Related Experiment Video
Updated: Feb 16, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
8.5K
Two-hundred Years Later: Is Parkinson's Disease a Single Defined Entity?
Mayela Rodríguez-Violante1, Amin Cervantes-Arriaga1, Stanley Fahn2
1Movement Disorders Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico, USA.
Summary
Parkinson's disease is evolving, with research exploring if it's one condition or multiple distinct diseases. Current evidence is insufficient to definitively classify Parkinson's disease, highlighting its complex nature.
Area of Science:
- Neurology
- Medical History
Background:
- James Parkinson first described "Shaking Palsy" in 1817.
- Jean-Martin Charcot later detailed motor features and named it Parkinson's disease.
Observation:
- The definition of Parkinson's disease has evolved with clinical and technological advancements.
- Factors like motor phenotype, non-motor symptoms, and genetic mutations challenge a singular disease concept.
Findings:
- The hypothesis suggests Parkinson's may encompass several diseases presenting as levodopa-responsive Parkinsonism.
- Current evidence is insufficient to confirm if Parkinson's is a single entity or multiple distinct conditions.
Implications:
- Understanding Parkinson's disease as potentially multiple conditions could revolutionize diagnosis and treatment.
- Further research is crucial to clarify the complex nature of Parkinson's disease and its subtypes.
Related Concept Videos
01:15Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:37Neural Regulation
43.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.5K
01:21EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
01:22Lysosomal Hydrolases
4.6K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.6K